ChartRow logo
Data provided bySource: Twelve Data
PeersDGXMTDOTISIQVWATILMN
Share this page

LH — Labcorp Holdings Inc. price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0
Data provided bySource: Twelve Data
What would $1,000 invested in LH be worth today? →
LH returns: By year · By month · By week · Trailing

Price data

Price
$366.57
YTD price return
+46.11%
YTD total return
+47.20%
Market cap
29.8B
Enterprise value
36.3B
Shares outstanding
81.2M
52W low
$244.52
52W high
$373.34
From 52W high
-1.81%
From 52W low
+49.91%
52W range
95%$245–$373
Beta
0.87

Volume

Rel volume
0.78×
30D volume
732.6K
30D $ vol
243.9M

Insider trading

Insider net 1W
−$108K
Insider net 1M
−$498K
Insider net 3M
−$2.9M
Insider net 1Y
−$10.9M

Form 4 transactions by trade date, as filed; latest on file 2026-11-03.

Fundamentals

Sales (ttm)
14.6B
Sales/share
$179.74
EPS (ttm)
$12.18
FCF (ttm)
1.3B
FCF/share
$15.85
Book value/share
$108.96
Net margin
6.88%
ROE
11.35%
ROA
5.31%
Debt / equity
0.59×
Current ratio
1.41

Growth (CAGR, ttm) · 10Y

Sales
+6.03%+6.86%-2.49%+4.62%
Net income
+17.41%+37.55%-18.33%+4.32%
FCF
-6.80%+15.11%-14.26%+4.59%
Shares
-2.05%-1.47%-3.23%-2.35%

Per-share growth (CAGR, ttm) · 10Y

EPS
+19.66%+40.64%-15.45%+6.78%
Sales/share
+8.25%+8.23%+0.77%+7.13%
FCF/share
-4.85%+16.59%-11.39%+7.10%
Book value/share
+3.87%+5.52%-0.18%+7.35%
Dividend/share
+0.00%-14.27%n/an/a
Price
+48.67%+20.49%+9.19%+13.34%
Total return
+50.17%+21.90%+10.36%+13.95%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
30.1×
P/OI (ttm)
19.8×
Fwd P/E
18.8×
P/S (ttm)
2.0×
P/B (mrq)
3.4×
P/FCF (ttm)
23.1×
EV/EBITDA (fy)
16.4×
EV/Sales (ttm)
2.5×
FCF yield (ttm)
4.32%
Dividend yield (fwd)Div yield
0.79%
Dividend yield (ttm)
0.79%
Dividend/share (fwd)
$2.88
Buyback yield (realized, 1y)
2.05%
Shareholder yield (realized, 1y)
3.05%
Buyback yield (cash, ttm)
2.27%
Shareholder yield (cash, ttm)
3.07%

Vs own 10Y history

P/E
81st
P/OI
88th
P/S
100th
P/B
100th
P/FCF
95th

Bar = where today’s multiple sits in LH’s own 10-year range:near a decade-low (cheap)→mid-range→near a decade-high (rich).

Performance · price returntotal return · as of 2026-11-06#

Data provided bySource: Twelve Data
1D
+0.90%
5D
+1.43%
1M
+17.60%
3M
+15.81%
YTD
+46.11%
1Y
+48.63%
5Y
+55.25%
1D
+0.90%
5D
+1.43%
1M
+17.60%
3M
+16.06%
YTD
+47.20%
1Y
+50.13%
5Y
+63.72%

Fundamentals#

Revenue

5Y CAGR −0.0%10Y CAGR +4.9%YoY +6.9%
$14.6B TTM$3.8B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q2 '16Q3 '16Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q3 '22Q2 '22Q4 '22Q1 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating income

5Y CAGR −10.8%10Y CAGR +3.3%YoY +1.4%
$1.5B TTM$402.1M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q2 '16Q3 '16Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q3 '22Q2 '22Q4 '22Q1 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

EPS (diluted)

5Y CAGR −8.0%10Y CAGR +9.2%YoY +3.2%
$12.18 TTM$3.22 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q2 '16Q3 '16Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q3 '22Q2 '22Q4 '22Q1 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

5Y CAGR −7.2%10Y CAGR +5.2%YoY +47.0%
$1.3B TTM$412.2M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM

TTM: operating cash flow $1.8B, capex −$528.1M

Q2 '16Q3 '16Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q3 '22Q2 '22Q4 '22Q1 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Q3 2026: operating cash flow $563.8M, capex −$151.6M

Shares (diluted)

5Y −14.5%10Y −16.7%YoY −2.5%
82.4M TTM81.6M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q2 '16Q3 '16Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q3 '22Q2 '22Q4 '22Q1 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Dividend per share

YoY +0.0%
$2.88 TTM$0.72 Q3 '26
FY22FY23FY24FY25TTM
Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Full LH financials →

Labcorp Holdings Inc. is a global life sciences and healthcare company that provides laboratory services to support clinical care, research, and drug development. Labcorp Holdings Inc. serves doctors, hospitals, pharmaceutical companies, researchers, and patients through a broad portfolio that includes routine and specialty diagnostic testing, central laboratory services, and early development research support. Its Diagnostics Laboratories segment covers testing in areas such as oncology, women’s health, autoimmune disease, and neurology, while its Biopharma Laboratory Services segment supports pharmaceutical and biotech clients with laboratory capabilities for clinical trials and development programs. The company plays a key role in healthcare by helping customers generate data used in diagnosis, treatment decisions, and biomedical research.

Burlington, NC·71,000 employees·Diagnostics & Research·labcorp.com·As of Oct 28, 2026

Recent filings#

All filings and insider trades →

ETFs holding LH#

33 of the 193 ETFs ChartRow carries live hold LH. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).

FundNameFiled weight
SPLVInvesco S&P 500 Low Volatility ETF0.9%
COWZPacer US Cash Cows 100 ETF0.5%
XLVHealth Care Select Sector SPDR Fund0.4%
VOEVanguard Mid-Cap Value ETF0.4%
VHTVanguard Health Care ETF0.4%
IWSiShares Russell Mid-Cap Value ETF0.2%
RSPInvesco S&P 500 Equal Weight ETF0.2%
VOVanguard Mid-Cap ETF0.2%
TickerName1M1D
LLYEli Lilly and Company+16.98%-0.79%
JNJJohnson & Johnson+8.42%+1.43%
ABBVAbbVie Inc.+9.23%+1.07%
MRKMerck & Co. Inc.+3.37%-0.14%
UNHUnitedHealth Group Incorporated Common Stock (DE)+4.74%-0.40%
NVSNovartis AG+15.46%+0.38%
TMOThermo Fisher Scientific Inc.+5.81%+2.63%
AMGNAmgen Inc.+14.36%+0.03%